David Meeker is Executive Vice President and General Manager of Sanofi Genzyme, the specialty care global business unit of Sanofi which focuses on rare diseases, multiple sclerosis, oncology, and immunology. As an Executive Vice President of Sanofi, he is a member of the Executive Committee.
Dr. Meeker joined Genzyme in 1994 as Medical Director to work on the Cystic Fibrosis Gene Therapy program. Subsequently, as Vice President, Medical Affairs, he was responsible for the development of rare disease therapies that today represent transformative and life-saving advancements in medicine for patients.
Prior to the merger with Sanofi in 2011, Dr. Meeker was Chief Operating Officer, responsible for Genzyme’s commercial organization, overseeing its business units¸ country management organization and global market access functions. In October 2011 he was appointed President and Chief Executive Officer of Genzyme, a Sanofi company. Prior to joining Genzyme, Dr. Meeker was the Director of the Pulmonary Critical Care Fellowship at the Cleveland Clinic and an assistant professor of medicine at Ohio State University. He has authored more than 40 articles and multiple book chapters.
Dr. Meeker received his MD from the University of Vermont Medical School. He completed an Internal Medicine residency at Beth Israel Hospital in Boston and a Pulmonary/Critical Care fellowship at Boston University. He completed the Advanced Management Program at Harvard Business School in 2000.